NIOSHTIC-2 Publications Search
Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap7).
Durkin-ME; Yuan-BZ; Thorgeirsson-SS; Popescu-NC
Gene 2002 Apr; 288(1-2):119-127
DLC-1 (deleted in liver cancer 1) is a candidate tumor suppressor gene for hepatocellular carcinoma and other cancers. It is the human homologue of rat p122, which has been shown to function as a GTPase activating protein for RhoA, and it may be involved in signal transduction pathways regulating cell proliferation and adhesion. To establish an animal model for studying the regulation and function of DLC-1, we have undertaken the characterization of the mouse DLC-1 gene. Northern blot analysis shows that the mouse DLC-1 mRNA is widely expressed, with the highest levels in heart, liver, and lung. Mouse genomic clones that contain the entire DLC-1 gene of 47 kb were isolated. The mouse gene consists of 14 exons, and the structural organization is highly similar to that of the human gene. The promoter region of the mouse gene was GC-rich and contained potential binding sites for transcription factors SP1, GCF, and AP-2. A polymorphic microsatellite marker in intron 8 was used for mapping the gene (Arhgap7) to 20 cM on mouse chromosome 8 and for allelotyping of mouse liver tumor DNAs.
Gene-mutation; Genes; Genetic-disorders; Genetic-factors; Genotoxic-effects; Cancer; Tumor-inhibition; Tumors; Liver-cancer; Liver-cells; Liver-tumors; Tumorigenesis; Animal-studies; DNA-damage; Amino-acids; Carcinomas; Proteins; Oncogenic-agents
Laboratory of Experimental Carcinogenesis, Building 37, Room 3C28, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Issue of Publication
Page last reviewed: April 12, 2019
Content source: National Institute for Occupational Safety and Health Education and Information Division